phase readout
saveNCT05809752: A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: PHASE1. Conditions: Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that